SCHEMBL5048006

SCHEMBL5048006

CC1CN(CC2CCOCC2)CC(C)N1C(C=O)SC(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 1/20 0.38
CACNA1H O95180 1/20 0.38
TACR2 P21452 1/20 0.38
HTR4 Q13639 9/20 0.37
CYP3A4 P08684 3/20 0.37
PRKCB P05771 2/20 0.36
CYP2D6 P10635 2/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
GBA1 P04062 1/20 0.32
OPRM1 P35372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047955 0.80 CACNA1G (0.39) CACNA1GCACNA1HTACR2HTR4CYP3A4
SCHEMBL5051949 0.77 TACR2 (0.37) CACNA1GCACNA1HTACR2HTR4CYP3A4
SCHEMBL4272230 0.74 TACR2 (0.42) CACNA1GCACNA1HTACR2HTR4CYP3A4
SCHEMBL4275673 0.68 TACR2 (0.46) TACR2HTR4CYP3A4PRKCBOPRM1
SCHEMBL4271169 0.67 TACR2 (0.43) CACNA1GCACNA1HTACR2HTR4CYP3A4
SCHEMBL8237608 0.66 SIGMAR1 (0.39) CACNA1GCACNA1HTACR2HTR4CYP3A4
SCHEMBL5049491 0.65 CACNA2D1 (0.43) CYP2D6CHRM2OPRM1
SCHEMBL5053738 0.65 TACR2 (0.38) TACR2HTR4CYP3A4CYP2D6CHRM2
SCHEMBL4273009 0.64 TACR2 (0.56) TACR2
SCHEMBL3326047 0.62 CACNA1G (0.55) CACNA1GCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976841-A1 HETEROCYCLIC AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Neuromed Pharmaceuticals, Ltd. (CA) 2008-10-08 EP claimed
WO-2007071035-A1 HETEROCYCLIC AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD. (CA) 2007-06-28 WO claimed